חוב לטווח קצר להון are.com (ARE)

Alexandria leverages powerful administrative resources and stringent medical standards within undersupplied US clusters. The establishment of research centers requires colossal investments and years of regulatory approvals. The risks associated with the narrow biotech laboratory niche are mitigated by the quality of the largest pharmaceutical tenants. The ratio of short-term debt to equity demonstrates the dynamics of the debt load, where the 0.03 mark serves as the current indicator.

Alexandria (ARE) generates a stable cash flow from long-term leases of biopharmaceutical laboratories, minimizing its reliance on external financing. This resilience directly impacts the current liabilities-to-capital ratio, reflecting the company's current debt load. This metric measures the proportion of loans maturing within one year, where an increase signals expansion or a liquidity deficit, while a decrease indicates financial security. The historical trend of the short-term debt-to-capital ratio confirms the overall capital management strategy.